The use of systems biology and immunological big data to guide vaccine development

High-throughput technologies applied to the analysis of vaccine responses are likely to reveal the mechanisms responsible for vaccine-induced protection, aid understanding of vaccine safety and help accelerate vaccine development and clinical trials.

Detalles Bibliográficos
Autores principales: Blohmke, Christoph J., O’Connor, Daniel, Pollard, Andrew J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Comment
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4641354/
https://www.ncbi.nlm.nih.gov/pubmed/26555212
http://dx.doi.org/10.1186/s13073-015-0236-1
_version_ 1782400186662780928
author Blohmke, Christoph J.
O’Connor, Daniel
Pollard, Andrew J.
author_facet Blohmke, Christoph J.
O’Connor, Daniel
Pollard, Andrew J.
author_sort Blohmke, Christoph J.
collection PubMed
description High-throughput technologies applied to the analysis of vaccine responses are likely to reveal the mechanisms responsible for vaccine-induced protection, aid understanding of vaccine safety and help accelerate vaccine development and clinical trials.
format Online
Article
Text
id pubmed-4641354
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-46413542015-11-12 The use of systems biology and immunological big data to guide vaccine development Blohmke, Christoph J. O’Connor, Daniel Pollard, Andrew J. Genome Med Comment High-throughput technologies applied to the analysis of vaccine responses are likely to reveal the mechanisms responsible for vaccine-induced protection, aid understanding of vaccine safety and help accelerate vaccine development and clinical trials. BioMed Central 2015-11-10 /pmc/articles/PMC4641354/ /pubmed/26555212 http://dx.doi.org/10.1186/s13073-015-0236-1 Text en © Blohmke et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Comment
Blohmke, Christoph J.
O’Connor, Daniel
Pollard, Andrew J.
The use of systems biology and immunological big data to guide vaccine development
title The use of systems biology and immunological big data to guide vaccine development
title_full The use of systems biology and immunological big data to guide vaccine development
title_fullStr The use of systems biology and immunological big data to guide vaccine development
title_full_unstemmed The use of systems biology and immunological big data to guide vaccine development
title_short The use of systems biology and immunological big data to guide vaccine development
title_sort use of systems biology and immunological big data to guide vaccine development
topic Comment
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4641354/
https://www.ncbi.nlm.nih.gov/pubmed/26555212
http://dx.doi.org/10.1186/s13073-015-0236-1
work_keys_str_mv AT blohmkechristophj theuseofsystemsbiologyandimmunologicalbigdatatoguidevaccinedevelopment
AT oconnordaniel theuseofsystemsbiologyandimmunologicalbigdatatoguidevaccinedevelopment
AT pollardandrewj theuseofsystemsbiologyandimmunologicalbigdatatoguidevaccinedevelopment
AT blohmkechristophj useofsystemsbiologyandimmunologicalbigdatatoguidevaccinedevelopment
AT oconnordaniel useofsystemsbiologyandimmunologicalbigdatatoguidevaccinedevelopment
AT pollardandrewj useofsystemsbiologyandimmunologicalbigdatatoguidevaccinedevelopment

Ejemplares similares